- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06095921
The Effect of a Self-Management Program on Individuals With Scleroderma
The Effect of Self-Management Programme Performed Via Telerehabilitation on Occupational Performance and Satisfaction of Individuals With Systemic Sclerosis
Introduction: Individuals with systemic sclerosis (SSc) have problems with perceived occupational performance and satisfaction in daily life activities due to many symptoms caused by the disease.
Purpose: This study will plan to examine the effect of a self-management program for individuals with SSc on perceived occupational performance and satisfaction.
Materials and Methods : Twenty-nine individuals with SSC, 28 females and 1 male will participate in the study. Perceived occupational performance and satisfaction levels before and after the program will evaluate with the Canadian Ocupational Performance Measure (COPM). The training programme will design according to the activities of COPM, the needs of the patients, and the literature. The programme consists of 8 sessions for 8 weeks, 1 day a week for 45 minutes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ankara
-
Çankaya, Ankara, Turkey, 06060
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Clinical diagnosis of Scleroderma's Disease, being in remission period for 6 months, being between the ages of 18-65, knowing how to use technological devices.
Exclusion criteria:
Neurological disease, continuing a different study or rehabilitation programme, having COVID-19 infection, exacerbation the disease in the last 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self Management Intervention Program
That program was created by sending 40-minute videos 1 day a week for 8 weeks.
The programme was developed both according to the achievements of previous self-management studies and according to the occupations that individuals with SSc have difficulty with.
|
SSc, the course of the disease, symptoms and coping strategies, medications and treatment methods?
The importance of exercise for individuals with SSc, and how to create an action plan for an exercise?
were discussed.
What are fatigue and its symptoms?
How can we protect our articular-energy and how should a quality rest be?
What is pain and what are coping approaches?
What is the pain-related area of influence?
What are body image problems, how to use problem solving approach and what is its importance?
What is Stress?
What is mindfulness?
What are mindfulness exercises?
What are the ways to cope with stress?
What are the daily life occupations and how can we facilitate them?
How can we solve problems in difficult occupations?
How to create an occupation plan to facilitate daily occupations?
What are oral stretching exercises and how to do them?
What are the factors affecting sleep?
What is advocacy and why is it important?
Answers to these questions were sought.
|
|
No Intervention: Statistical Analysis
One week after the program, the biostatistician evaluated the results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Canadian Occupational Performance Measurement (COPM)
Time Frame: One week before the rehabilitation program is implemented.
|
COPM was developed in 1990.
The scale determines the daily life occupations experienced by individuals in the areas of self-care, productivity and leisure time.
It grades the occupational performance and satisfaction points of these determined occupations according to the Likert scale between 1-10.
A minimum of one and a maximum of 5 occupations could be written, resulted in a total performance and satisfaction point.
The average performance and satisfaction points were divided by the number of readings.
The highest point that can be obtained from the scale is 10 and the lowest point is 1.
The Turkish cultural adaptation, validity and reliability study of the scale was conducted by Torpil in 2017 in individuals with multiple sclerosis and the test-retest reliability of the Turkish version was found to be 0.98.
|
One week before the rehabilitation program is implemented.
|
|
Canadian Occupational Performance Measurement (COPM)
Time Frame: One week after the rehabilitation program ended.
|
COPM was developed in 1990.
The scale determines the daily life occupations experienced by individuals in the areas of self-care, productivity and leisure time.
It grades the occupational performance and satisfaction points of these determined occupations according to the Likert scale between 1-10.
A minimum of one and a maximum of 5 occupations could be written, resulted in a total performance and satisfaction point.
The average performance and satisfaction points were divided by the number of readings.
The highest point that can be obtained from the scale is 10 and the lowest point is 1.
The Turkish cultural adaptation, validity and reliability study of the scale was conducted by Torpil in 2017 in individuals with multiple sclerosis and the test-retest reliability of the Turkish version was found to be 0.98.
|
One week after the rehabilitation program ended.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERG-EMIRHAN-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.